![]() In this Seminar, we provide an overview of recent evidence regarding the epidemiology, pathogenesis, diagnosis, and treatment of Alzheimer's disease, and discuss potential ways to reduce the risk of developing the disease.Ĭopyright © 2011 Elsevier Ltd. ![]() There is now strong evidence of potential risk and protective factors for Alzheimer's disease, dementia, and cognitive decline, but further work is needed to understand these better and to establish whether interventions can substantially lower these risks. TOD’S S.p.A.: Appointment of a non executive member of the Board of Directors. Strong performance of Greater China and Roger Vivier. Excellent performance of the E-Commerce channel. Methods for improving diagnosis are also moving forward, but a better consensus is needed for development of a panel of biological and neuroimaging biomarkers that support clinical diagnosis. Strong sales results and visible profitability recovery in the first half of 2021. Although there are licensed treatments that can alleviate symptoms of Alzheimer's disease, there is a pressing need to improve our understanding of pathogenesis to enable development of disease-modifying treatments. Thus, Alzheimer's disease represents a major public health concern and has been identified as a research priority. An estimated 24 million people worldwide have dementia, the majority of whom are thought to have Alzheimer's disease. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |